Literature DB >> 21744118

HIV-1 effects on neuropsychological performance in a resource-limited country, Zambia.

Adelina Holguin1, Mwanza Banda, Elizabeth J Willen, Costantine Malama, Kaseya O Chiyenu, Victor C Mudenda, Charles Wood.   

Abstract

Zambia has substantially been affected by the HIV/AIDS epidemic with prevalence rates at 14% in a population estimated at 12 million. Yet, the extent of HIV-associated neurocognitive disorders (HAND) in this population remains to be clearly understood. A series of culturally appropriate neuropsychological (NP) assessments [International HIV Dementia Scale (IHDS), Color Trails Test 1 and 2, Grooved pegboard Test, and Time Gait Test] were used to test the effects of HIV on NP performance of HIV seropositive and seronegative individuals. Twenty-two percent HIV positive individuals ARV naïve met the criteria for IHDS-defined NP impairment. Gender significantly influenced the performance on NP tests with females performing more poorly compared to males. Larger studies that will accommodate gender differences and age are necessary to generate appropriate norms in Zambia in order to better assess the prevalence of HAND in the developing country setting.

Entities:  

Mesh:

Year:  2011        PMID: 21744118      PMCID: PMC3314062          DOI: 10.1007/s10461-011-9988-9

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  37 in total

1.  Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals.

Authors:  M A Cole; J B Margolick; C Cox; X Li; O A Selnes; E M Martin; J T Becker; H A Aronow; B Cohen; N Sacktor; E N Miller
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

2.  Variable progression of HIV-associated dementia.

Authors:  F H Bouwman; R L Skolasky; D Hes; O A Selnes; J D Glass; T E Nance-Sproson; W Royal; G J Dal Pan; J C McArthur
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

3.  Characterization of HIV-Associated Neurocognitive Disorders among individuals starting antiretroviral therapy in South Africa.

Authors:  John A Joska; Jennifer Westgarth-Taylor; Landon Myer; Jacqueline Hoare; Kevin G F Thomas; Marc Combrinck; Robert H Paul; Dan J Stein; Alan J Flisher
Journal:  AIDS Behav       Date:  2011-08

4.  The International HIV Dementia Scale: a new rapid screening test for HIV dementia.

Authors:  Ned C Sacktor; Matthew Wong; Noeline Nakasujja; Richard L Skolasky; Ola A Selnes; Seggane Musisi; Kevin Robertson; Justin C McArthur; Allan Ronald; Elly Katabira
Journal:  AIDS       Date:  2005-09-02       Impact factor: 4.177

5.  Opportunistic pathogens in AIDS: trends, diagnosis and priorities.

Authors:  Harleen M S Grewal; Swati Gupta; Sarman Singh
Journal:  Expert Rev Anti Infect Ther       Date:  2008-04       Impact factor: 5.091

6.  WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings.

Authors:  M Maj; P Satz; R Janssen; M Zaudig; F Starace; L D'Elia; B Sughondhabirom; M Mussa; D Naber; D Ndetei
Journal:  Arch Gen Psychiatry       Date:  1994-01

7.  Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study.

Authors:  J C McArthur; D R Hoover; H Bacellar; E N Miller; B A Cohen; J T Becker; N M Graham; J H McArthur; O A Selnes; L P Jacobson
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

8.  Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia.

Authors:  David B Clifford; Mesfin T Mitike; Yared Mekonnen; Jiameng Zhang; Guta Zenebe; Zenebe Melaku; Ayele Zewde; Neway Gessesse; Dawit Wolday; Tsehaynesh Messele; Mengesha Teshome; Scott Evans
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

9.  Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaoundé-Cameroon.

Authors:  A K Njamnshi; A C Zoung-Kanyi Bissek; P Ongolo-Zogo; E N Tabah; A Z Lekoubou; F N Yepnjio; J Y Fonsah; C T Kuate; S A Angwafor; F Dema; D M Njamnshi; C Kouanfack; V de P Djientcheu; W F T Muna; G D Kanmogne
Journal:  J Neurol Sci       Date:  2009-07-24       Impact factor: 3.181

10.  Cognitive performance after progression to AIDS: a longitudinal study from the Multicenter AIDS Cohort Study.

Authors:  O A Selnes; N Galai; H Bacellar; E N Miller; J T Becker; J Wesch; W Van Gorp; J C McArthur
Journal:  Neurology       Date:  1995-02       Impact factor: 9.910

View more
  25 in total

1.  Use of Western Neuropsychological Test Battery in Detecting HIV-Associated Neurocognitive Disorders (HAND) in Zambia.

Authors:  Norma Kabuba; J Anitha Menon; Donald R Franklin; Robert K Heaton; Knut A Hestad
Journal:  AIDS Behav       Date:  2017-06

Review 2.  Effect of HIV clade differences on the onset and severity of HIV-associated neurocognitive disorders.

Authors:  William Tyor; Cari Fritz-French; Avindra Nath
Journal:  J Neurovirol       Date:  2013-10-16       Impact factor: 2.643

3.  Neurocognitive Impairment Risk Among Individuals With Multiple Drug-Resistant Tuberculosis and Human Immunodeficiency Virus Coinfection: Implications for Systematic Linkage to and Retention of Care in Tuberculosis/Human Immunodeficiency Virus Treatment.

Authors:  Andrew Tomita; Suvira Ramlall; Thirusha Naidu; Sbusisiwe Sandra Mthembu; Nesri Padayatchi; Jonathan K Burns
Journal:  J Nerv Ment Dis       Date:  2019-04       Impact factor: 2.254

Review 4.  Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review.

Authors:  Alain Lekoubou; Justin B Echouffo-Tcheugui; Andre P Kengne
Journal:  BMC Public Health       Date:  2014-06-26       Impact factor: 3.295

5.  Cognitive impairment and psychiatric morbidity in HIV+ Zambians with new-onset seizure.

Authors:  Lisa Kalungwana; Melissa A Elafros; Omar K Siddiqi; Christopher M Bositis; Izukanji Sikazwe; Igor J Koralnik; William H Theodore; Gretchen L Birbeck
Journal:  Am J Trop Med Hyg       Date:  2014-10-13       Impact factor: 2.345

6.  Acute EEG findings in HIV-infected Zambian adults with new-onset seizure.

Authors:  Omar K Siddiqi; Melissa A Elafros; Izukanji Sikazwe; Gretchen L Birbeck; Lisa Kalungwana; Michael J Potchen; Christopher M Bositis; Igor J Koralnik; William H Theodore
Journal:  Neurology       Date:  2015-03-04       Impact factor: 9.910

7.  Sex-based differences in neurocognitive functioning in HIV-infected young adults.

Authors:  Ruxandra Burlacu; Anya Umlauf; Anca Luca; Sara Gianella; Roxana Radoi; Simona M Ruta; Thomas D Marcotte; Luminita Ene; Cristian L Achim
Journal:  AIDS       Date:  2018-01-14       Impact factor: 4.177

8.  Trail Making Test A improves performance characteristics of the International HIV Dementia Scale to identify symptomatic HAND.

Authors:  Thep Chalermchai; Victor Valcour; Pasiri Sithinamsuwan; Suteeraporn Pinyakorn; David Clifford; Robert H Paul; Somporn Tipsuk; James L K Fletcher; Victor Degruttola; Silvia Ratto-Kim; Nicholas Hutchings; Cecilia Shikuma; Jintanat Ananworanich
Journal:  J Neurovirol       Date:  2013-03-13       Impact factor: 2.643

9.  Functional impairment, disability, and frailty in adults aging with HIV-infection.

Authors:  Kristine M Erlandson; Jennifer A Schrack; Catherine M Jankowski; Todd T Brown; Thomas B Campbell
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

10.  Global NeuroAIDS roundtable.

Authors:  Jeymohan Joseph; Cristian L Achim; Michael J Boivin; Bruce J Brew; David B Clifford; Deborah A Colosi; Ronald J Ellis; Robert K Heaton; Amadou Gallo-Diop; Igor Grant; Georgette D Kanmogne; Mahendra Kumar; Scott Letendre; Thomas D Marcotte; Avindra Nath; Carlos A Pardo; Robert H Paul; Lynn Pulliam; Kevin Robertson; Walter Royal; Ned Sacktor; Pasiri Sithinamsuwan; Davey M Smith; Victor Valcour; Brian Wigdahl; Charles Wood
Journal:  J Neurovirol       Date:  2013-01-26       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.